Recent Posts in Mesothelioma Category
130 results found. Viewing page 1 of 6.
Go to page
Researchers from Rice University and Baylor College of Medicine have managed to eradicate advanced-stage mesothelioma tumors within days on rodent subjects, laying the groundwork for future human trials. By combining cytokine “drug ...
Continue Reading...
U.S. Representative Elaine Luria of Virginia has introduced legislation to prohibit state courts from removing cases to the federal court system. Throughout the United States, when asbestos victims seek restitution from the companies that knowingly ...
Continue Reading...
The Pacific Meso Center’s 11th Annual Walk/Hike for Mesothelioma is less than a month away! The walk will be held on Sunday, September 25, 2022. You can either join other walkers at Kenneth Hahn Park in Baldwin Hills (family and animal ...
Continue Reading...
The U.S. Food and Drug Administration (FDA) has designated Fast Track status to a new therapeutic drug therapy for the treatment of malignant pleural mesothelioma (MPM) in patients with unresectable NF2-deficient tumors. The drug, IK-930, was granted ...
Continue Reading...
SELLAS Life Sciences Group (SELLAS) has announced promising results of a Phase 1 clinical trial of the combination of immunotherapy agents Galinpepimut-S (GPS) and nivolumab for patients with WT1 positive malignant pleural mesothelioma. GPS is an ...
Continue Reading...
Researchers in Japan are working to develop an inhalable powder as a new form of treatment for non-small cell lung cancer and mesothelioma. The inhalable powder is a form of gene therapy containing tumor suppression drugs SFD-p16 and SFD-p53 which ...
Continue Reading...
Despite the overall decreased use of asbestos nationwide, mesothelioma deaths among women still managed to increase by 25% over the past two decades. This according to death record statistics published by the Centers for Disease Control and ...
Continue Reading...
Researchers at Memorial Sloan Kettering Cancer Center (MSK) have published promising results of a phase 2 clinical trial for patients with pleural mesothelioma found to have a BAP1 genetic mutation. According to the researchers, the BAP1 mutation is ...
Continue Reading...
A Federal Appeals Court will revisit the controversial ruling allowing Johnson & Johnson to use the Texas Two-Step tactic to transfer individual talc lawsuits to mass bankruptcy claims. In February, a U.S. Bankruptcy Court Judge sided with ...
Continue Reading...
Johnson & Johnson voted against a proposal to end sales of its talc-based baby powder globally at its annual shareholder meeting on April 28, 2022. The company stopped selling talc-based baby powder in the US and Canada in 2020 after an ...
Continue Reading...
The Pacific Meso Center’s 11th Annual Walk/Hike for Mesothelioma is coming up! The walk will be held on Sunday, September 25, 2022. You can either join other walkers at Kenneth Hahn Park in Baldwin Hills or choose to participate virtually with ...
Continue Reading...
The University of Hawaii Cancer Center has published novel research on the BAP1 genetic mutation found in an estimated 10% of patients with mesothelioma with the goal of better understanding the unique traits of carriers of the mutation. Michele ...
Continue Reading...
Researchers in the U.K. have published a systemic review analyzing 598 pleural mesothelioma patients that have undergone hyperthermic intrathoracic chemotherapy (“HITHOC”) immediately following surgery in the hopes of eradicating ...
Continue Reading...
Last month the Environmental Protection Agency under the Biden Administration announced a landmark proposal to ban the use, manufacture and import of Chrysotile asbestos in the United States, a move long coming since the US halted production of the ...
Continue Reading...
Despite the recent EPA proposed ban on the use, manufacture and import of Chrysotile asbestos, the U.S. still faces the ongoing crisis of confronting the asbestos that remains in public buildings and homes. Also known as “legacy” ...
Continue Reading...
Johnson & Johnson is being forced into a shareholder vote today, Thursday, April 28, at its 2022 Annual Shareholder meeting to end all sales of its talc-based baby powder globally. The company ceased sales of the product in the US and Canada in ...
Continue Reading...
HBO’s new documentary series, Not So Pretty, takes a critical investigative look at the beauty industry and the numerous health risks associated with certain cosmetics products. The first episode, “Makeup,” highlights the hidden ...
Continue Reading...
On Saturday, April 16 th, over 100 riders took part in the 7 th Annual Greatest Escape Motorcycle Rally for Mesothelioma Research. Worthington & Caron was proud to once again serve as lead sponsor and participate in this one-of-a-kind motorcycle ...
Continue Reading...
The Environmental Protection Agency recently proposed banning the use, manufacture and import of Chrysotile asbestos, the most ubiquitous type of asbestos. The landmark proposal intending to restrict asbestos, signals the first time the federal ...
Continue Reading...
Unsealed documents from more than 50 years ago, reveal that Johnson & Johnson funded experiments on prison inmates to examine the effects of talc. Bloomberg News reports that J&J’s involvement in these controversial talc studies was not ...
Continue Reading...
The asbestos attorneys of Worthington & Caron, P.C. are pleased to report that on February 16, 2022, a Santa Monica Jury awarded $5 million to our clients in a case entitled Brooks vs. Kaiser Gypsum Company, Inc., et al. (LASC Case No. ...
Continue Reading...
Speaking from the U.S. Senate floor on February 15, Sen. Dick Durbin condemned Johnson & Johnson’s controversial bankruptcy strategy, which he labeled “shameful and indefensible”, to limit their massive legal liability to ...
Continue Reading...
Once again leading the charge, Reuters issued a special report detailing the bombshell story of how Johnson & Johnson strategized the plan to limit compensation to asbestos talc victims. Back in 2018, Reuters published an investigative report ...
Continue Reading...
Last week the U.S. Food and Drug Administration, in conjunction with their Interagency Working Group on Asbestos in Consumer Products, released a document containing the opinions of scientific experts suggesting changes to the FDA’s current ...
Continue Reading...
The National Cancer Institute is currently recruiting malignant pleural or peritoneal mesothelioma patients for a phase I clinical trial aimed at patients unable to undergo surgery and who have not responded to standard first-line treatments for ...
Continue Reading...
130 results found. Viewing page 1 of 6.
Go to page